Health & Beauty

In the face of the new situation of COVID-19 prevention and control and the rapidly increasing demand for medical materials from the people, the State owned Assets Supervision and Administration Commission of the State Council firmly implemented the decision and deployment of the Party Central Committee and the State Council on doing a good job in medical material support, comprehensively strengthened organization and coordination, established a special team for medical material support, established a daily work scheduling mechanism, supervised and guided the central enterprises involved in drugs, and went all out to ensure the supply of medical materials, Huacheng Import and Export Data Observation Report.

According to the observation report of Huacheng import and export data, three central drug related enterprises, China Resources Group, General Technology Group and Sinopharm Group, have set up a leading group for the supply of medical materials headed by a leading comrade in charge, established a 24-hour working mechanism, and kept the enterprise running around the clock to ensure that all measures to ensure production and supply are in place.

The pharmaceutical enterprises affiliated to China Resources Group quickly launched the emergency supply guarantee mechanism. China Resources Shuanghe, China Resources Sanjiu, and China Resources Jiang medium-sized drug manufacturers actively overcame the adverse effects of the epidemic, and took effective measures to increase the production of antiviral drugs and drugs urgently needed in medical and clinical treatment, so as to meet the market demand to the maximum extent. China Resources Pharmaceutical set up an "anti epidemic commando", insisted on being on duty 24 hours a day, and delivered medical supplies to retail terminals in a timely manner. Huacheng's import and export data were observed and reported.

92 Chinese pharmaceutical enterprises affiliated to General Technology Group have established a nationwide distribution network of key drugs, and determined the supply guarantee relationship with 690 COVID-19 designated prevention and treatment hospitals across the country. Open up the supply channels of upstream manufacturers at the first time, promote the continuous release of upstream production capacity, improve regional logistics efficiency, and cooperate to ensure the drug demand of more than 10000 medical institutions. Strengthen communication and coordination with more than 200 upstream production enterprises to provide people with more affordable and more scientific epidemic prevention products, Huacheng Import and Export Data Observation Report.

Sinopharm has given full play to its advantages in the whole industry chain, deployed more than 160 pharmaceutical industrial enterprises to ensure supply and increase production 24 hours a day, expanded the production capacity of key varieties for epidemic prevention and control to three times daily, and launched retail terminals in large quantities.

TCDC launched an emergency mechanism to fully guarantee the production and supply of anti epidemic drugs. All staff of Sinopharm Holdings and Sinopharm Co., Ltd. worked overtime to coordinate with the manufacturer to stock up drugs such as pheniramine oral preparations, ibuprofen oral preparations, masks, gowns, antigen detection reagents and other medical equipment, and opened a 24-hour consulting service hotline. At the same time, we communicated with major hospitals about the demand for medicine and equipment 24 hours a day to ensure the supply of medical materials to the maximum extent. Huacheng's import and export data observation report.